Clinical Services > Respiratory

Lung health clinicians and researchers recognised

25 March, 2024

Fourteen lung health clinicians and researchers have been recognised as a part of TSANZ's 2024 Respiratory Research Excellence Awards.


New resource to help asthma patients sleep well

11 March, 2024

The National Asthma Council of Australia has released a resource to help health professionals treat patients who present with poor asthma control and sleep disturbance.


Getinge Neurally Adjusted Ventilatory Assist (NAVA)

13 February, 2024

Getinge's Neurally Adjusted Ventilatory Assist was developed to use the patient's own neural respiratory drive to control the ventilator.


Study suggests a new way to treat sleep apnoea

16 October, 2023

A research team has examined shortcomings in responses to the continuous positive airway machine and found adding combinations of therapies gets results in those unable to tolerate CPAP.


TGA seizes 40,000 vapes in Qld

01 September, 2023

The Therapeutic Goods Administration (TGA) has seized over 40,000 vaping products, with an estimated street value of over $1.2 million, in Brisbane.


Lipid-lowering drugs could impair lung function: study

24 July, 2023

A study involving 340,000 UK Biobank participants has found that a new class of cholesterol-lowering drugs could impair lung function in some patients.


1 in 5 people could be suffering from OSA, but most are unaware

15 May, 2023

People with OSA often snore loudly, their breathing starts and stops during the night and they may wake up several times.


NAC releases new First Aid for Asthma Chart

14 April, 2023

The National Asthma Council Australia (NAC) has released a significant new chart that provides guidance for the use of preventer and reliever combinations in an emergency.


OSA may directly cause cognitive decline

11 April, 2023

Patients with obstructive sleep apnoea (OSA) often show cognitive deficits, but these have traditionally been attributed to comorbidities such as systemic hypertension, cardiovascular and metabolic diseases, and type 2 diabetes.


"We can't make the same mistake twice"

21 March, 2023 by Victoria Keays, Partner at Gordon Legal

A painful lung disease caused by inhaling harmful levels of silica dust, silicosis is costing Australian tradies their jobs and, ultimately, their lives.


Childhood LRTI linked to premature death: Lancet

10 March, 2023

Respiratory infections contracted during early childhood are associated with an increased risk of death from respiratory illness between 26 and 73 years of age.


"Crazy interesting": lung protein that could block COVID-19

10 February, 2023

A protein in the lung could form a natural protective barrier to SARS-CoV-2 in humans, as reported by University of Sydney scientists in PLOS Biology.


Asthma preventer medicine overprescribed

01 August, 2022

Professor Helen Reddel and colleagues from the Woolcock Institute of Medical Research have written about finding the lowest effective dose to control asthma.


Virtual lung therapy delivered through a smartphone app

01 August, 2022

A browser-based smartphone app delivers therapy for people recovering from surgery and those with lung conditions involving overproduction of mucus.


Some flu vaccine reactions could be misdiagnosed as anaphylaxis

04 July, 2022

Some adverse reactions to influenza vaccinations could be stress-related responses being misdiagnosed as anaphylaxis.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd